Bekanamycin
|  | |
| Systematic (IUPAC) name | |
|---|---|
| (2S,3R,4S,5S,6R)-4-amino-2-{[(2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names | 
| Legal status | 
 | 
| Identifiers | |
| CAS Number | 4696-76-8  | 
| ATC code | J01GB13 (WHO) | 
| PubChem | CID 439318 | 
| ChemSpider | 388449  | 
| UNII | 15JT14C3GI  | 
| ChEBI | CHEBI:28098  | 
| ChEMBL | CHEMBL176  | 
| NIAID ChemDB | 005087 | 
| Chemical data | |
| Formula | C18H37N5O10 | 
| Molar mass | 483.51 g/mol | 
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Bekanamycin (INN, or kanamycin B) is an aminoglycoside antibiotic.[1]
References
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.